March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Tear-Derived Cathepsin S Activity as a Novel Diagnostic Marker for Sjögren's Syndrome
Author Affiliations & Notes
  • Kavita Renduchintala
    These authors contributed equally to this work,
    Keck School of Medicine of USC, Los Angeles, California
  • Starleen E. Whitt
    These authors contributed equally to this work,
    Keck School of Medicine of USC, Los Angeles, California
  • Srikanth Janga
    USC School of Pharmacy, Los Angeles, California
  • Mihir Shah
    USC School of Pharmacy, Los Angeles, California
  • Martin Heur
    Doheny Eye Institute, Los Angeles, California
  • John Irvine
    Doheny Eye Institute, Los Angeles, California
  • Daniel Arkfeld
    Keck School of Medicine of USC, Los Angeles, California
  • Wendy J. Mack
    Keck School of Medicine of USC, Los Angeles, California
  • William Stohl
    Keck School of Medicine of USC, Los Angeles, California
  • Sarah F. Hamm-Alvarez
    USC School of Pharmacy, Los Angeles, California
  • Footnotes
    Commercial Relationships  Kavita Renduchintala, None; Starleen E. Whitt, None; Srikanth Janga, None; Mihir Shah, None; Martin Heur, None; John Irvine, None; Daniel Arkfeld, None; Wendy J. Mack, None; William Stohl, None; Sarah F. Hamm-Alvarez, None
  • Footnotes
    Support  USC Stevens Ideas Empowered Grant
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4240. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kavita Renduchintala, Starleen E. Whitt, Srikanth Janga, Mihir Shah, Martin Heur, John Irvine, Daniel Arkfeld, Wendy J. Mack, William Stohl, Sarah F. Hamm-Alvarez; Tear-Derived Cathepsin S Activity as a Novel Diagnostic Marker for Sjögren's Syndrome. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4240.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the utility of Cathepsin S (CATS) as a biomarker for diagnosing Sjögren’s Syndrome (SjS), CATS levels in the tears of patients with SjS were compared to CATS levels in patients with other forms of autoimmune diseases and keratoconjuctivitis sicca (KCS). Current markers utilized for diagnosis of SjS include SSA/SBB autoantigens; however, these markers lack sensitivity and specificity in unequivocally diagnosing SjS.

Methods: : 111 patients were recruited. Schirmer’s tests were administered to 41 patients diagnosed with primary or secondary SjS, 23 patients with Rheumatoid Arthritis (RA) without secondary SjS, 17 patients with Systemic Lupus Erythematosus (SLE) without secondary SjS, 20 patients with other autoimmune diseases without secondary SjS, and 10 patients with KCS. Schirmer’s strips were placed on ice after tear collection. Tear proteins were subsequently eluted and analyzed within 4 hours for CATS activity using the BioVision Cathepsin S Activity Assay Kits with Ac-Val-Val-Arg-7-Amino-4-trifluoromethylcoumarin as substrate. Protein content of the tears was measured using the Bio-Rad assay and CATS activity was expressed as normalized to protein content. SSA and SSB levels were also measured in blood from autoimmune disease patients.

Results: : The mean CATS activity/tear protein values, expressed below as RFU/20 µg tear protein, were determined for each group and statistically compared by t-tests. The CATS activity value for SjS was 7945.4 ± 1045.3, significantly elevated compared to 3727.8 ± 923.9 for RA (p =.003), 2852.4 ± 534.3 for SLE (p=.00003), and 2624.56 ± 914.7 for KCS (p=.0003). Patients with primary SjS (n=11) averaged 9063.4 ±1932.3 in comparison to patients with secondary SjS (n=30) who averaged 7535.4 ± 972.8 (p=0.41). Within the diagnosed SjS patients group, CATS activity for SSA+/SSB+ and SSA+/SSB- patients was 9445.1 ± 1335.7, compared to 3485.8 ± 931.6 for SSA-/SSB- patients (p=.001).

Conclusions: : CATS tear activity is a potential diagnostic marker for SjS, due to the markedly elevated levels of CATS in tears of SjS patients compared to those in patients with RA, SLE or KCS. A correlation between CATS activity and SSA+ autoantigen is also evident.

Keywords: lacrimal gland • inflammation • protein structure/function 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×